RUOL, ARTURO
 Distribuzione geografica
Continente #
NA - Nord America 1.664
AS - Asia 502
EU - Europa 327
AF - Africa 122
SA - Sud America 92
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
Totale 2.736
Nazione #
US - Stati Uniti d'America 1.595
SG - Singapore 175
CN - Cina 138
HK - Hong Kong 68
BR - Brasile 46
FI - Finlandia 41
DE - Germania 38
SE - Svezia 30
FR - Francia 23
NL - Olanda 23
GB - Regno Unito 18
IT - Italia 18
UA - Ucraina 16
RU - Federazione Russa 14
AR - Argentina 11
CA - Canada 11
AO - Angola 10
HN - Honduras 10
IN - India 10
PY - Paraguay 9
PL - Polonia 8
AT - Austria 7
ET - Etiopia 7
GH - Ghana 7
IQ - Iraq 7
MX - Messico 7
CL - Cile 6
DZ - Algeria 6
NZ - Nuova Zelanda 6
PH - Filippine 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
TR - Turchia 6
VN - Vietnam 6
BZ - Belize 5
CW - ???statistics.table.value.countryCode.CW??? 5
HU - Ungheria 5
JO - Giordania 5
KR - Corea 5
ML - Mali 5
MZ - Mozambico 5
NC - Nuova Caledonia 5
PS - Palestinian Territory 5
SI - Slovenia 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
AD - Andorra 4
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
BE - Belgio 4
BF - Burkina Faso 4
BG - Bulgaria 4
CH - Svizzera 4
CO - Colombia 4
CR - Costa Rica 4
CZ - Repubblica Ceca 4
DJ - Gibuti 4
ES - Italia 4
ID - Indonesia 4
IE - Irlanda 4
IL - Israele 4
IS - Islanda 4
LU - Lussemburgo 4
MA - Marocco 4
MR - Mauritania 4
MW - Malawi 4
MY - Malesia 4
NE - Niger 4
PK - Pakistan 4
PT - Portogallo 4
RW - Ruanda 4
SO - Somalia 4
UG - Uganda 4
UY - Uruguay 4
YE - Yemen 4
ZA - Sudafrica 4
AF - Afghanistan, Repubblica islamica di 3
AL - Albania 3
BA - Bosnia-Erzegovina 3
BJ - Benin 3
BY - Bielorussia 3
CG - Congo 3
CM - Camerun 3
DK - Danimarca 3
EC - Ecuador 3
GF - Guiana Francese 3
GM - Gambi 3
GP - Guadalupe 3
HR - Croazia 3
HT - Haiti 3
JP - Giappone 3
KE - Kenya 3
KG - Kirghizistan 3
LC - Santa Lucia 3
ME - Montenegro 3
MG - Madagascar 3
MN - Mongolia 3
NI - Nicaragua 3
NP - Nepal 3
Totale 2.648
Città #
Fairfield 206
Chandler 159
Houston 153
Woodbridge 151
Singapore 127
Ashburn 116
Ann Arbor 110
Santa Clara 76
Wilmington 75
Seattle 73
Jacksonville 69
Hong Kong 65
Cambridge 61
Boardman 35
Princeton 34
Beijing 33
Des Moines 23
Nanjing 21
Medford 19
San Diego 17
Helsinki 12
Los Angeles 12
Roxbury 10
Guangzhou 9
Luanda 8
Nanchang 7
Accra 6
Addis Ababa 6
Munich 6
Stockholm 6
Amman 5
Bamako 5
Bytom 5
Falkenstein 5
Jiaxing 5
Maputo 5
Noumea 5
São Paulo 5
Tegucigalpa 5
Vienna 5
Andorra la Vella 4
Changsha 4
Hebei 4
Ho Chi Minh City 4
Istanbul 4
Jinan 4
Kampala 4
Kigali 4
London 4
Luxembourg 4
New Taipei City 4
New York 4
Nouakchott 4
Ouagadougou 4
San Pedro Sula 4
Shenyang 4
Toronto 4
Asunción 3
Auckland 3
Baghdad 3
Baku 3
Bangkok 3
Belgrade 3
Boston 3
Brazzaville 3
Castries 3
Cotonou 3
Djibouti 3
Dublin 3
Managua 3
Montevideo 3
Montreal 3
Niamey 3
Norwalk 3
Ottawa 3
Panama City 3
Podgorica 3
Pristina 3
San José 3
Sanaa 3
Sarajevo 3
Sofia 3
Taizhou 3
Turku 3
Ulan Bator 3
Antananarivo 2
Apia 2
Belize City 2
Bishkek 2
Blantyre 2
Bratislava 2
Brest 2
Brussels 2
Budapest 2
Casablanca 2
Cayenne 2
Chaguanas 2
Cuiabá 2
Dakar 2
Domžale 2
Totale 1.937
Nome #
Human epithelial growth factor receptor 2 (HER2) status in primary and metastatic esophagogastric junction adenocarcinomas. 167
bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer 166
Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. 163
Theophylline pharmacokinetics and liver function indexes in chronic liver disease. 141
Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. 141
Renal effects of nadolol in cirrhosis. 140
P53 OVEREXPRESSION IN THE MULTISTEP PROCESS OF ESOPHAGEAL CARCINOGENESIS 139
Nadolol for prevention of variceal rebleeding in cirrhosis: a controlled clinical trial. 134
Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. 133
Evaluation of renal tubular damage in liver cirrhosis by urinary enzymes and beta-2-microglobulin excretions. 114
Proteinuria in patients with cirrhosis: relationship between renal and hepatic function. 108
Enhanced renal sympathetic tone in liver cirrhosis: evaluation by intrarenal administration of dihydroergocristine. 108
Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. 104
Kidney and malignant hypertension. Anatomical and clinical aspects 103
Only Pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery Alone 102
Long-term effect of nadolol, on quantitative liver function tests in patients with cirrhosis. 99
The calcium-channel blocker, Verapamil, does not improve portal pressure in patients with alco¬holic cirrhosis. 96
Effetto della somatostatina sull'emodinamica splancnica nella cirrosi. 95
Effect of intrarenal administration of bumetanide on renal haemodynamic and function in patients with liver cirrhosis. 91
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis: comparison with the Pugh score. 85
Ipertensione portale 84
Esophageal carcinosarcoma: management and prognosis at a single Italian series 80
L'impiego dei beta-bloccanti nell'ipertensione portale in corso di cirrosi epatica: efficacia ed applicabilità. 73
Hypophosphatemia and renal tubular dysfunction in alcoholics: are they related to liver function impairment? 71
Totale 2.737
Categoria #
all - tutte 9.372
article - articoli 9.092
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 280
Totale 18.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202195 0 0 0 8 5 9 0 23 20 12 13 5
2021/2022271 6 40 27 18 17 15 14 28 12 6 27 61
2022/2023270 44 41 2 43 40 50 0 10 28 3 5 4
2023/202496 4 15 7 10 9 20 1 2 5 0 15 8
2024/2025523 1 30 39 30 101 22 20 48 27 16 71 118
2025/2026580 70 130 191 189 0 0 0 0 0 0 0 0
Totale 2.737